Literature DB >> 30178633

Regulatory T cells and asthma.

Sheng-Tao Zhao1,2, Chang-Zheng Wang1.   

Abstract

Asthma is a chronic disease of airway inflammation due to excessive T helper cell type 2 (Th2) response. Present treatment based on inhalation of synthetic glucocorticoids can only control Th2-driven chronic eosinophilic inflammation, but cannot change the immune tolerance of the body to external allergens. Regulatory T cells (Tregs) are the main negative regulatory cells of the immune response. Tregs play a great role in regulating allergic, autoimmune, graft-versus-host responses, and other immune responses. In this review, we will discuss the classification and biological characteristics, the established immunomodulatory mechanisms, and the characteristics of induced differentiation of Tregs. We will also discuss the progress of Tregs in the field of asthma. We believe that further studies on the regulatory mechanisms of Tregs will provide better treatments and control strategies for asthma.

Entities:  

Keywords:  Regulatory T cell; Asthma; Transforming growth factor β (TGF-β); Interleukin 10 (IL-10); IL-35

Mesh:

Substances:

Year:  2018        PMID: 30178633      PMCID: PMC6137416          DOI: 10.1631/jzus.B1700346

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  77 in total

1.  Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity.

Authors:  Noriko Komatsu; Maria Encarnita Mariotti-Ferrandiz; Ying Wang; Bernard Malissen; Herman Waldmann; Shohei Hori
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-27       Impact factor: 11.205

Review 2.  Use of gene-modified regulatory T-cells to control autoimmune and alloimmune pathology: is now the right time?

Authors:  Hannah Jethwa; Antonella A Adami; John Maher
Journal:  Clin Immunol       Date:  2013-11-16       Impact factor: 3.969

3.  Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota.

Authors:  June L Round; Sarkis K Mazmanian
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

Review 4.  Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity.

Authors:  Silvia Deaglio; Simon C Robson
Journal:  Adv Pharmacol       Date:  2011

5.  Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma.

Authors:  Nandini Krishnamoorthy; Anupriya Khare; Timothy B Oriss; Mahesh Raundhal; Christina Morse; Manohar Yarlagadda; Sally E Wenzel; Martin L Moore; R Stokes Peebles; Anuradha Ray; Prabir Ray
Journal:  Nat Med       Date:  2012-09-09       Impact factor: 53.440

6.  Adoptive transfer of ex vivo expanded regulatory T cells in an autoimmune hepatitis murine model restores peripheral tolerance.

Authors:  Pascal Lapierre; Kathie Béland; Roland Yang; Fernando Alvarez
Journal:  Hepatology       Date:  2012-10-01       Impact factor: 17.425

Review 7.  Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells.

Authors:  M Sitkovsky; D Lukashev; S Deaglio; K Dwyer; S C Robson; A Ohta
Journal:  Br J Pharmacol       Date:  2008-03       Impact factor: 8.739

8.  Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells.

Authors:  Pervinder Sagoo; Niwa Ali; Garima Garg; Frank O Nestle; Robert I Lechler; Giovanna Lombardi
Journal:  Sci Transl Med       Date:  2011-05-18       Impact factor: 17.956

9.  An asthma-associated IL4R variant exacerbates airway inflammation by promoting conversion of regulatory T cells to TH17-like cells.

Authors:  Amir Hossein Massoud; Louis-Marie Charbonnier; David Lopez; Matteo Pellegrini; Wanda Phipatanakul; Talal A Chatila
Journal:  Nat Med       Date:  2016-08-01       Impact factor: 53.440

10.  Pathogenicity of a disease-associated human IL-4 receptor allele in experimental asthma.

Authors:  Raffi Tachdjian; Clinton Mathias; Shadi Al Khatib; Paul J Bryce; Hong S Kim; Frank Blaeser; Brian D O'Connor; Danuta Rzymkiewicz; Andrew Chen; Michael J Holtzman; Gurjit K Hershey; Holger Garn; Hani Harb; Harald Renz; Hans C Oettgen; Talal A Chatila
Journal:  J Exp Med       Date:  2009-09-21       Impact factor: 14.307

View more
  22 in total

Review 1.  Vaccine Potential of Mycobacterial Antigens against Asthma.

Authors:  Abu Salim Mustafa
Journal:  Med Princ Pract       Date:  2020-05-18       Impact factor: 1.927

2.  Protective effects of methane-rich saline on mice with allergic asthma by inhibiting inflammatory response, oxidative stress and apoptosis.

Authors:  Ning Zhang; Hong-Tao Lu; Rong-Jia Zhang; Xue-Jun Sun
Journal:  J Zhejiang Univ Sci B       Date:  2019 Oct.       Impact factor: 3.066

3.  Sex Hormones and Lung Inflammation.

Authors:  Jorge Reyes-García; Luis M Montaño; Abril Carbajal-García; Yong-Xiao Wang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children.

Authors:  J Loske; J Röhmel; S Lukassen; S Stricker; V G Magalhães; J Liebig; R L Chua; L Thürmann; M Messingschlager; A Seegebarth; B Timmermann; S Klages; M Ralser; B Sawitzki; L E Sander; V M Corman; C Conrad; S Laudi; M Binder; S Trump; R Eils; M A Mall; I Lehmann
Journal:  Nat Biotechnol       Date:  2021-08-18       Impact factor: 68.164

Review 5.  Emerging Insights into the Impact of Air Pollution on Immune-Mediated Asthma Pathogenesis.

Authors:  J A Tuazon; B Kilburg-Basnyat; L M Oldfield; R Wiscovitch-Russo; K Dunigan-Russell; A V Fedulov; K J Oestreich; K M Gowdy
Journal:  Curr Allergy Asthma Rep       Date:  2022-04-08       Impact factor: 4.919

Review 6.  Epigenetic regulation of pediatric and neonatal immune responses.

Authors:  Jennifer Bermick; Matthew Schaller
Journal:  Pediatr Res       Date:  2021-07-08       Impact factor: 3.756

7.  Cornuside alleviates experimental autoimmune encephalomyelitis by inhibiting Th17 cell infiltration into the central nervous system.

Authors:  Rongbo Zhang; Jin Liu; Bin Xu; You Wu; Shunli Liang; Qiang Yuan
Journal:  J Zhejiang Univ Sci B       Date:  2021-05-15       Impact factor: 3.066

8.  Serum macrophage migration inhibitory factor as a potential biomarker to evaluate therapeutic response in patients with allergic asthma: an exploratory study.

Authors:  Huiyuan Zhu; Shaochun Yan; Jingshuo Wu; Zhong Zhang; Xiaolin Li; Zheng Liu; Xing Ma; Lina Zhou; Lin Zhang; Mingming Feng; Yiwei Geng; Aixin Zhang; Sabina Janciauskiene; Aiguo Xu
Journal:  J Zhejiang Univ Sci B       Date:  2021-06-15       Impact factor: 3.066

9.  TGFβ1 mimetic peptide modulates immune response to grass pollen allergens in mice.

Authors:  Galber R Araujo; Lorenz Aglas; Emília R Vaz; Yoan Machado; Sara Huber; Martin Himly; Albert Duschl; Luiz R Goulart; Fatima Ferreira
Journal:  Allergy       Date:  2019-12-12       Impact factor: 13.146

10.  Interleukin-35 sensitizes monocytes from patients with asthma to glucocorticoid therapy by regulating p38 MAPK.

Authors:  Lei Qian; Donghui Xu; Fangsu Xue; Ming Li; Xushan Wang; Guangliang Liu
Journal:  Exp Ther Med       Date:  2020-03-09       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.